|
T.TST
|
but then you will miss the most interesting part: on p75 (again). just by...
|
|
T.TST
|
Clinical Trial Design Issues for the Development of New Therapies for...
|
|
T.TST
|
Endo Health Solutions just announced a big acquisition. The company&...
|
|
T.TST
|
so BNC can dilute to a billion shares to match the price, great...
|
|
T.TST
|
as per Endo itself, UROCIDIN is a 100 millions, One hundred million estimated...
|
|
T.TST
|
By Peter E. Clark, MD1 | September 15, 2013 1<%
|
|
T.TST
|
By Peter E. Clark, MD1 | September 15, 2013 1 Department of Urologic Surgery,...
|
|
T.TST
|
2013-09-15 1,447,848 222,500 ...
|
|
T.TST
|
shorts
2013-08-31 1,225,348 402,848 105,890,404 1.16%
2013-08-15 822,500...
|
|
T.TST
|
(Reuters) - Canada's largest listed drug maker, Valeant Pharmaceuticals...
|
|
T.TST
|
update on where are the others and some stuff: RNN Rexahn complete...
|
|
T.TST
|
Further, based on discussions with the FDA, Spectrum has agreed to conduct...
|
|
T.TST
|
Pierre Fabre Drug Fails to Win NICE Backing for Bladder Cancer
...
|
|
T.TST
|
Current understanding and perspectives on engineered BCG vaccine
Since the...
|
|
T.TST
|
THE interests of the food and agriculture industries were given higher...
|
|
T.TST
|
yep link not working(?) from the message but working if you copy paste into...
|
|
T.TST
|
cytokine you said: Bioggio, Switzerland, 7th January 2013 - Telormedix, a...
|
|
T.TST
|
an 3/13 Jan 2/13 Shea, Jennifer Louise&...
|
|
T.TST
|
you are right, they seem to have many things to deal with: Endo...
|
|
T.TST
|
only 600K...
|